These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8369467)

  • 1. Early intervention of inotropic support in facilitating weaning from cardiopulmonary bypass: the New England Deaconess Hospital experience.
    Lewis KP
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4 Suppl 2):40-5. PubMed ID: 8369467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inotropic support of the heart that fails to successfully wean from cardiopulmonary bypass: the Montreal Heart Institute experience.
    Hardy JF; Belisle S
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4 Suppl 2):33-9. PubMed ID: 8103681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amrinone in cardiac surgical patients with left-ventricular dysfunction. A prospective, randomized placebo-controlled trial.
    Butterworth JF; Royster RL; Prielipp RC; Lawless ST; Wallenhaupt SL
    Chest; 1993 Dec; 104(6):1660-7. PubMed ID: 8252937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bolus dose of 1.5 mg/kg amrinone effectively improves low cardiac output state following separation from cardiopulmonary bypass in cardiac surgical patients.
    Kikura M; Levy JH; Bailey JM; Shanewise JS; Michelsen LG; Sadel SM
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):825-33. PubMed ID: 9698960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial dysfunction following cardiopulmonary bypass: recovery patterns, predictors of inotropic need, theoretical concepts of inotropic administration.
    Royster RL
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4 Suppl 2):19-25. PubMed ID: 8369465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of amrinone in treating heart failure during and after coronary artery surgery supported by cardiopulmonary bypass.
    Wynands JE
    J Card Surg; 1994 May; 9(3 Suppl):453-8. PubMed ID: 8069035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of a new inotropic agent, enoximone, in heart surgery].
    Gomar C; Fita G; Pomar JL; Valero R; Mulet J; Nalda MA
    Rev Esp Anestesiol Reanim; 1991; 38(2):121-6. PubMed ID: 1678896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amrinone in perioperative low cardiac output syndrome.
    Fita G; Gomar C; Jimenez MJ; Pacheco M; Mulet J; Nalda MA
    Acta Anaesthesiol Scand; 1990 Aug; 34(6):482-5. PubMed ID: 2239121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative insulin therapy does not reduce the need for inotropic or antiarrhythmic therapy after cardiopulmonary bypass.
    Groban L; Butterworth J; Legault C; Rogers AT; Kon ND; Hammon JW
    J Cardiothorac Vasc Anesth; 2002 Aug; 16(4):405-12. PubMed ID: 12154416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amrinone, in combination with norepinephrine, is an effective first-line drug for difficult separation from cardiopulmonary bypass.
    Hardy JF; Searle N; Roy M; Perrault J
    Can J Anaesth; 1993 Jun; 40(6):495-501. PubMed ID: 8403112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: a comparison of their effects on hemodynamics and outcome.
    Dupuis JY; Bondy R; Cattran C; Nathan HJ; Wynands JE
    J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):542-53. PubMed ID: 1421065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful use of levosimendan in a patient during cardiopulmonary bypass.
    Iriz E; Erer D; Unal Y; Zor H; Ozkose Z; Ozdogan ME
    J Card Surg; 2007; 22(2):153-6. PubMed ID: 17338755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An amrinone bolus prior to weaning from cardiopulmonary bypass improves cardiac function in mitral valve surgery patients.
    Badner NH; Murkin JM; Shannon NA
    J Cardiothorac Vasc Anesth; 1994 Aug; 8(4):410-4. PubMed ID: 7948796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of amrinone or adrenaline on low cardiac output following cardiopulmonary bypass in patients with coronary artery disease undergoing preoperative beta-blockade.
    Günnicker M; Brinkmann M; Donovan TJ; Freund U; Schieffer M; Reidemeister JC
    Thorac Cardiovasc Surg; 1995 Jun; 43(3):153-60. PubMed ID: 7570567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk calculation of inotropic support in patients undergoing cardiac surgery with cardiopulmonary bypass using an automated anaesthesia record-keeping system.
    Müller M; Junger A; Bräu M; Kwapisz MM; Schindler E; Akintürk H; Benson M; Hempelmann G
    Br J Anaesth; 2002 Sep; 89(3):398-404. PubMed ID: 12402717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined inotropic effects of amrinone and epinephrine after cardiopulmonary bypass in humans.
    Royster RL; Butterworth JF; Prielipp RC; Zaloga GP; Lawless SG; Spray BJ; Kon ND; Wallenhaupt SL; Cordell AR
    Anesth Analg; 1993 Oct; 77(4):662-72. PubMed ID: 8214647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, blind comparison of amrinone with milrinone after elective cardiac surgery.
    Rathmell JP; Prielipp RC; Butterworth JF; Williams E; Villamaria F; Testa L; Viscomi C; Ittleman FP; Baisden CE; Royster RL
    Anesth Analg; 1998 Apr; 86(4):683-90. PubMed ID: 9539583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of amrinone and norepinephrine for inotropic support during emergence from cardiopulmonary bypass.
    Lathi KG; Shulman MS; Diehl JT; Stetz JJ
    J Cardiothorac Vasc Anesth; 1991 Jun; 5(3):250-4. PubMed ID: 1863745
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic amrinone for weaning from cardiopulmonary bypass.
    Lewis KP; Appadurai IR; Pierce ET; Halpern EF; Bode RH
    Anaesthesia; 2000 Jul; 55(7):627-33. PubMed ID: 10919416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure.
    Surgenor SD; DeFoe GR; Fillinger MP; Likosky DS; Groom RC; Clark C; Helm RE; Kramer RS; Leavitt BJ; Klemperer JD; Krumholz CF; Westbrook BM; Galatis DJ; Frumiento C; Ross CS; Olmstead EM; O'Connor GT
    Circulation; 2006 Jul; 114(1 Suppl):I43-8. PubMed ID: 16820613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.